Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON44344Phase 3Active, not recruiting
Phase 3, randomised trial in asthenia comparing Modafinil, Caffeine and Placebo (3 arms). Primary endpoints: Vigilance & Tracking Test (VigTrack) root mean square of tracking error, Vigilance & Tracking Test (VigTrack) percentage omissions and 4 more. Started Dec 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON44344.